Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome - Gangale, M F; Miele, L; Lanzone, A (Clin Endocrinol, 2011)
et al.